IL17A and pneumonia: The number of group 3 ILCs producing IL-17 also increases during K. pneumoniae-induced pneumonia, which helps in the resolution of pulmonary inflammation at later stages to prevent the development of ALI during pneumonia (Figure 2A) (141).